The BET-bromodomain Inhibitor JQ1 Renders Neuroblastoma Cells More Resistant to NK Cell-Mediated Recognition and Killing by Downregulating Ligands for NKG2D and DNAM1 Receptors

Oncotarget - United States
doi 10.18632/oncotarget.26736
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

The Bromodomain BET Inhibitor JQ1 Suppresses Tumor Angiogenesis in Models of Childhood Sarcoma

Molecular Cancer Therapeutics
Cancer ResearchOncology
2016English

Increase of NKG2D Ligands and Sensitivity to NK Cell-Mediated Cytotoxicity of Tumor Cells by Heat Shock and Ionizing Radiation

Experimental & Molecular Medicine
2006English

Sensitization of Tumor Cells to NK Cell-Mediated Killing by Proteasome Inhibition

Journal of Immunology
AllergyImmunology
2007English

A Role for NKG2D in NK Cell–Mediated Resistance to Poxvirus Disease

PLoS Pathogens
ImmunologyMolecular BiologyVirologyMicrobiologyParasitologyGenetics
2008English

NKG2D Signaling Leads to NK Cell Mediated Lysis of Childhood AML

Journal of Immunology Research
MedicineAllergyImmunology
2015English

The Requirement for DNAM-1, NKG2D, and NKp46 in the Natural Killer Cell-Mediated Killing of Myeloma Cells

Cancer Research
Cancer ResearchOncology
2007English

Nanog Requires BRD4 to Maintain Murine Embryonic Stem Cell Pluripotency and Is Suppressed by Bromodomain Inhibitor JQ1 Together With Lefty1

Stem Cells and Development
Developmental BiologyHematologyCell Biology
2015English

Cutting Edge: Tumor-Targeting Antibodies Enhance NKG2D-Mediated NK Cell Cytotoxicity by Stabilizing NK Cell-Tumor Cell Interactions

Journal of Immunology
AllergyImmunology
2012English

The Interaction Between CD300a and Phosphatidylserine Inhibits Tumor Cell Killing by NK Cells

European Journal of Immunology
AllergyImmunology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy